Stocks News

LAST PRICE
244.6800
TODAY'S CHANGE (%)
Trending Down-0.1600 (-0.0653%)

Bid / Lots
---/ ---
Ask / Lots
---/ ---
Open / Previous Close
247.2900 / 244.8400
Day Range
Low 243.8750
High 249.8600
52 Week Range
Low 148.0000
High 277.3400
Volume
422,387
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Penumbra Insider Sold Shares Worth $3,559,176, According to a Recent SEC Filing, from 3:16AM ET on Monday Nov 25, 2024 by MT Newswires
  3:16AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: PEN
  03:16 AM EST, 11/25/2024 (MT Newswires) -- Adam Elsesser, Director, Chief Executive Officer and President, on November 20, 2024, sold 15,000 shares in Penumbra (PEN) for $3,559,176. Following the Form 4 filing with the SEC, Elsesser has control over...
Nov 20, 2024
- Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Wednesday Nov 20, 2024 by PR Newswire
  4:30PM ET on Wednesday Nov 20, 2024 by PR Newswire
  Companies Mentioned: PEN
  Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the PiperSandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024.
  https://mma.prnewswire.com/media/282131/penumbra_logo.jpg
- Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Wednesday Nov 20, 2024 by Dow Jones
  4:30PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: PEN
  
  Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
  
  PR Newswire
  
  ALAMEDA, Calif., Nov. 20, 2024
  
  ALAMEDA, Calif., Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36(th) Annual Healthcare Conference on Wednesday, December 4, 2024.
- DJ Penumbra Is Maintained at Overweight by Piper Sandler, from 1:13PM ET on Wednesday Nov 20, 2024 by Dow Jones
  1:13PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: PEN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PEN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 20, 2024 13:13 ET (18:13 GMT)
Nov 5, 2024
- New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options, from 9:01AM ET on Tuesday Nov 05, 2024 by PR Newswire
  9:01AM ET on Tuesday Nov 05, 2024 by PR Newswire
  Companies Mentioned: PEN
  -- Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference
  -- Findings reinforce the clinical, health economic and cost benefits of computer assisted vacuum thrombectomy to patients and the overall health system

Nov 22, 2024
- Repligen Insider Sold Shares Worth $3,386,439, According to a Recent SEC Filing, from 5:00PM ET on Friday Nov 22, 2024 by MT Newswires
  5:00PM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: RGEN
- DJ Masimo Price Target Raised to $190.00/Share From $170.00 by Stifel, from 10:14AM ET on Friday Nov 22, 2024 by Dow Jones
  10:14AM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: MASI
Nov 21, 2024
- Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference, from 9:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  9:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
Nov 18, 2024
- DJ Bio-Rad Laboratories On Track for Longest Losing Streak Since January 2022 -- Data Talk, from 11:05AM ET on Monday Nov 18, 2024 by Dow Jones
  11:05AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
Nov 15, 2024
- DJ Bio-Rad Laboratories Down Over 6%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk, from 12:13PM ET on Friday Nov 15, 2024 by Dow Jones
  12:13PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
Nov 14, 2024
- Masimo to Present in the Jefferies London Healthcare Conference, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: MASI
- DJ Repligen Initiated at Peer Perform by Wolfe Research, from 8:53AM ET on Thursday Nov 14, 2024 by Dow Jones
  8:53AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: RGEN
- Wolfe Research Initiates Repligen at Peer Perform, from 8:28AM ET on Thursday Nov 14, 2024 by MT Newswires
  8:28AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: RGEN
Nov 13, 2024
- UBS Adjusts Price Target on Repligen to $190 From $185, Keeps Buy Rating, from 12:13PM ET on Wednesday Nov 13, 2024 by MT Newswires
  12:13PM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: RGEN
- Masimo to Present in Stifel 2024 Healthcare Conference, from 9:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  9:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: MASI

Penumbra Inc
NYSE:PENUnited States

Search Criteria

Yesterday

Penumbra Insider Sold Shares Worth $3,559,176, According to a Recent SEC Filing, from 3:16AM ET on Monday Nov 25, 2024 by MT Newswires

Nov 20, 2024

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Wednesday Nov 20, 2024 by PR Newswire

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Wednesday Nov 20, 2024 by Dow Jones

DJ Penumbra Is Maintained at Overweight by Piper Sandler, from 1:13PM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 5, 2024

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options, from 9:01AM ET on Tuesday Nov 05, 2024 by PR Newswire

Peers Headlines

Nov 22, 2024

Repligen Insider Sold Shares Worth $3,386,439, According to a Recent SEC Filing, from 5:00PM ET on Friday Nov 22, 2024 by MT Newswires

DJ Masimo Price Target Raised to $190.00/Share From $170.00 by Stifel, from 10:14AM ET on Friday Nov 22, 2024 by Dow Jones

Nov 21, 2024

Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference, from 9:00AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 18, 2024

DJ Bio-Rad Laboratories On Track for Longest Losing Streak Since January 2022 -- Data Talk, from 11:05AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 15, 2024

DJ Bio-Rad Laboratories Down Over 6%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk, from 12:13PM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

Masimo to Present in the Jefferies London Healthcare Conference, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones

DJ Repligen Initiated at Peer Perform by Wolfe Research, from 8:53AM ET on Thursday Nov 14, 2024 by Dow Jones

Wolfe Research Initiates Repligen at Peer Perform, from 8:28AM ET on Thursday Nov 14, 2024 by MT Newswires

Nov 13, 2024

UBS Adjusts Price Target on Repligen to $190 From $185, Keeps Buy Rating, from 12:13PM ET on Wednesday Nov 13, 2024 by MT Newswires

Masimo to Present in Stifel 2024 Healthcare Conference, from 9:00AM ET on Wednesday Nov 13, 2024 by Dow Jones